{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T15:57:44Z","timestamp":1772553464068,"version":"3.50.1"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Anusandhan National Research Foundation","award":["SRG\/2023\/000538"],"award-info":[{"award-number":["SRG\/2023\/000538"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11621-4","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T12:27:41Z","timestamp":1772540861000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unraveling the \u03b1V\u03b25\u2013GLUT5 axis in breast cancer: linking extracellular matrix signaling to fructose metabolism: a scoping review"],"prefix":"10.1007","volume":"53","author":[{"given":"Rahul S.","family":"Tade","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilip L.","family":"Pawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pravin O.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashant B.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"11621_CR1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70011","volume-title":"Cancer treatment and survivorship statistics, 2025","author":"NS Wagle","year":"2025","unstructured":"Wagle NS et al (2025) Cancer treatment and survivorship statistics, 2025. A Cancer Journal for Clinicians, CA"},{"key":"11621_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.29289\/25945394202020200024","volume":"30","author":"RG do Nascimento","year":"2020","unstructured":"do Nascimento RG, Otoni KM (2020) Histological and molecular classification of breast cancer: what do we know? Mastology 30:1\u20138","journal-title":"Mastology"},{"key":"11621_CR3","doi-asserted-by":"crossref","unstructured":"Fatima S (2025) Tumor Microenvironment: A Complex Landscape of Cancer Development and Drug Resistance. Cureus 17(4):e82090","DOI":"10.7759\/cureus.82090"},{"issue":"10","key":"11621_CR4","doi-asserted-by":"publisher","first-page":"11149","DOI":"10.1002\/cam4.5698","volume":"12","author":"Q Wang","year":"2023","unstructured":"Wang Q et al (2023) Role of tumor microenvironment in cancer progression and therapeutic strategy. Cancer Med 12(10):11149\u201311165","journal-title":"Cancer Med"},{"issue":"9","key":"11621_CR5","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.3390\/genes13091585","volume":"13","author":"Y Dekker","year":"2022","unstructured":"Dekker Y et al (2022) Crosstalk between hypoxia and extracellular matrix in the tumor microenvironment in breast cancer. Genes 13(9):1585","journal-title":"Genes"},{"key":"11621_CR6","unstructured":"Kannan S (2021) Characterization of Proliferation and Migration of Breast Cancer Cells Targeted by a GLUT5-Specific Fructose Mimic. Michigan Technological University"},{"issue":"1","key":"11621_CR7","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3390\/cancers12010154","volume":"12","author":"AM Barbosa","year":"2020","unstructured":"Barbosa AM, Martel F (2020) Targeting glucose transporters for breast cancer therapy: the effect of natural and synthetic compounds. Cancers 12(1):154","journal-title":"Cancers"},{"issue":"11","key":"11621_CR8","doi-asserted-by":"publisher","first-page":"e26902","DOI":"10.1371\/journal.pone.0026902","volume":"6","author":"G Gowrishankar","year":"2011","unstructured":"Gowrishankar G et al (2011) GLUT 5 is not over-expressed in breast cancer cells and patient breast cancer tissues. PLoS ONE 6(11):e26902","journal-title":"PLoS ONE"},{"key":"11621_CR9","doi-asserted-by":"crossref","unstructured":"Giaquinto AN et al (2022) Breast cancer statistics, 2022. A cancer journal for clinicians, CA 72(6):524\u2013541","DOI":"10.3322\/caac.21754"},{"key":"11621_CR10","doi-asserted-by":"crossref","unstructured":"Siegel RL et al (2026) Cancer statistics, 2026. CA: A Cancer Journal for Clinicians. 76(1):e70043","DOI":"10.3322\/caac.70043"},{"issue":"2","key":"11621_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3322\/caac.21874","volume":"75","author":"AH Saka","year":"2025","unstructured":"Saka AH et al (2025) Cancer statistics for African American and Black people. Cancer J Clin 75(2):111\u2013140. https:\/\/doi.org\/10.3322\/caac.21874","journal-title":"Cancer J Clin"},{"issue":"1","key":"11621_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/his.14786","volume":"82","author":"EA Rakha","year":"2023","unstructured":"Rakha EA, Tse GM, Quinn CM (2023) An update on the pathological classification of breast cancer. Histopathology 82(1):5\u201316","journal-title":"Histopathology"},{"issue":"1","key":"11621_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/PPO.0000000000000500","volume":"27","author":"FM Howard","year":"2021","unstructured":"Howard FM, Olopade OI (2021) Epidemiology of triple-negative breast cancer: a review. Cancer J 27(1):8\u201316","journal-title":"Cancer J"},{"key":"11621_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13058-020-01369-5","volume":"22","author":"S Bhattarai","year":"2020","unstructured":"Bhattarai S et al (2020) Quadruple-negative breast cancer: novel implications for a new disease. Breast Cancer Res 22:1\u201311","journal-title":"Breast Cancer Res"},{"key":"11621_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13058-020-01296-5","volume":"22","author":"L Yin","year":"2020","unstructured":"Yin L et al (2020) Triple-negative breast cancer molecular subtyping and treatment progress. Breast Cancer Res 22:1\u201313","journal-title":"Breast Cancer Res"},{"issue":"12","key":"11621_CR16","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.3390\/cancers12123716","volume":"12","author":"R Hass","year":"2020","unstructured":"Hass R, von der Ohe J, Ungefroren H (2020) Impact of the tumor microenvironment on tumor heterogeneity and consequences for cancer cell plasticity and stemness. Cancers 12(12):3716","journal-title":"Cancers"},{"issue":"3","key":"11621_CR17","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41594-024-01211-y","volume":"31","author":"NM Mattson","year":"2024","unstructured":"Mattson NM et al (2024) A novel class of inhibitors that disrupts the stability of integrin heterodimers identified by CRISPR-tiling-instructed genetic screens. Nat Struct Mol Biol 31(3):465\u2013475. https:\/\/doi.org\/10.1038\/s41594-024-01211-y","journal-title":"Nat Struct Mol Biol"},{"issue":"5","key":"11621_CR18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1042\/CS20210679","volume":"136","author":"N Kolesnikoff","year":"2022","unstructured":"Kolesnikoff N, Chen C-H, Samuel MS (2022) Interrelationships between the extracellular matrix and the immune microenvironment that govern epithelial tumour progression. Clin Sci 136(5):361\u2013377","journal-title":"Clin Sci"},{"key":"11621_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-021-01428-1","volume":"20","author":"X Mao","year":"2021","unstructured":"Mao X et al (2021) Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer 20:1\u201330","journal-title":"Mol Cancer"},{"issue":"6","key":"11621_CR20","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/s41388-020-01588-2","volume":"40","author":"H Yousefi","year":"2021","unstructured":"Yousefi H et al (2021) Understanding the role of integrins in breast cancer invasion, metastasis, angiogenesis, and drug resistance. Oncogene 40(6):1043\u20131063","journal-title":"Oncogene"},{"key":"11621_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10911-011-9226-0","volume":"16","author":"PJ Keely","year":"2011","unstructured":"Keely PJ (2011) Mechanisms by which the extracellular matrix and integrin signaling act to regulate the switch between tumor suppression and tumor promotion. J Mammary Gland Biol Neoplasia 16:205\u2013219","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"1","key":"11621_CR22","doi-asserted-by":"publisher","first-page":"e70009","DOI":"10.1002\/mog2.70009","volume":"4","author":"Y Tan","year":"2025","unstructured":"Tan Y et al (2025) Unraveling the underlying mechanisms of cancer stem cells in therapeutic resistance for optimizing treatment strategies. MedComm\u2013Oncology 4(1):e70009","journal-title":"MedComm\u2013Oncology"},{"issue":"1","key":"11621_CR23","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41392-020-00313-5","volume":"5","author":"S Qin","year":"2020","unstructured":"Qin S et al (2020) Emerging role of tumor cell plasticity in modifying therapeutic response. Signal Transduct Target therapy 5(1):228","journal-title":"Signal Transduct Target therapy"},{"issue":"2","key":"11621_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/cells8020089","volume":"8","author":"N Gandhi","year":"2019","unstructured":"Gandhi N, Das GM (2019) Metabolic reprogramming in breast cancer and its therapeutic implications. Cells 8(2):89","journal-title":"Cells"},{"issue":"1","key":"11621_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-024-02165-x","volume":"23","author":"S Liu","year":"2024","unstructured":"Liu S et al (2024) Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer. Mol Cancer 23(1):1\u201357","journal-title":"Mol Cancer"},{"issue":"5","key":"11621_CR26","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s12094-019-02187-8","volume":"22","author":"Z Wu","year":"2020","unstructured":"Wu Z et al (2020) Emerging roles of aerobic glycolysis in breast cancer. Clin Transl Oncol 22(5):631\u2013646","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"11621_CR27","doi-asserted-by":"publisher","first-page":"5436","DOI":"10.1038\/s41467-020-19263-1","volume":"11","author":"J Kim","year":"2020","unstructured":"Kim J et al (2020) Ketohexokinase-A acts as a nuclear protein kinase that mediates fructose-induced metastasis in breast cancer. Nat Commun 11(1):5436","journal-title":"Nat Commun"},{"key":"11621_CR28","unstructured":"Tang G (2019) Ketohexokinase and fructose metabolism promote pancreatic cancer growth by activating MAPK signaling pathway. ETH Zurich"},{"issue":"4","key":"11621_CR29","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.3390\/ijerph20043596","volume":"20","author":"M Lubawy","year":"2023","unstructured":"Lubawy M, Formanowicz D (2023) High-fructose diet\u2013induced hyperuricemia accompanying metabolic syndrome\u2013mechanisms and dietary therapy proposals. Int J Environ Res Public Health 20(4):3596","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"11621_CR30","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1002\/hep.26594","volume":"58","author":"T Ishimoto","year":"2013","unstructured":"Ishimoto T et al (2013) High-fat and high\u2010sucrose (western) diet induces steatohepatitis that is dependent on fructokinase. Hepatology 58(5):1632\u20131643","journal-title":"Hepatology"},{"issue":"1","key":"11621_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40170-020-00222-9","volume":"8","author":"T Nakagawa","year":"2020","unstructured":"Nakagawa T et al (2020) Fructose contributes to the Warburg effect for cancer growth. Cancer Metabolism 8(1):1\u201312","journal-title":"Cancer Metabolism"},{"key":"11621_CR32","doi-asserted-by":"crossref","unstructured":"Moldogazieva NT, Mokhosoev IM, Terentiev AA, Cancers (2020) 12(4): p. 862","DOI":"10.3390\/cancers12040862"},{"key":"11621_CR33","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.canlet.2018.10.015","volume":"442","author":"S Wen","year":"2019","unstructured":"Wen S et al (2019) Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin \u03b23\u2013p38 MAPK signalling. Cancer Lett 442:320\u2013332","journal-title":"Cancer Lett"},{"issue":"8","key":"11621_CR34","doi-asserted-by":"publisher","first-page":"dju169","DOI":"10.1093\/jnci\/dju169","volume":"106","author":"KM Moore","year":"2014","unstructured":"Moore KM et al (2014) Therapeutic targeting of integrin \u03b1v\u03b26 in breast cancer. J Natl Cancer Inst 106(8):dju169","journal-title":"J Natl Cancer Inst"},{"key":"11621_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-019-1056-8","volume":"38","author":"DC Rigiracciolo","year":"2019","unstructured":"Rigiracciolo DC et al (2019) Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells. J Experimental Clin Cancer Res 38:1\u201316","journal-title":"J Experimental Clin Cancer Res"},{"issue":"4","key":"11621_CR36","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/iub.303","volume":"62","author":"JL Guan","year":"2010","unstructured":"Guan JL (2010) Integrin signaling through FAK in the regulation of mammary stem cells and breast cancer. IUBMB Life 62(4):268\u2013276","journal-title":"IUBMB Life"},{"key":"11621_CR37","doi-asserted-by":"publisher","first-page":"114980","DOI":"10.1016\/j.ecoenv.2023.114980","volume":"258","author":"Q Liu","year":"2023","unstructured":"Liu Q et al (2023) Perfluoroalkyl substances promote breast cancer progression via ER\u03b1 and GPER mediated PI3K\/Akt and MAPK\/Erk signaling pathways. Ecotoxicol Environ Saf 258:114980","journal-title":"Ecotoxicol Environ Saf"},{"issue":"3","key":"11621_CR38","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3892\/ol.2023.13990","volume":"26","author":"H Yi","year":"2023","unstructured":"Yi H et al (2023) Prognostic impact of the combination of HIF\u20131\u03b1 and GLUT1 in patients with oesophageal squamous cell carcinoma. Oncol Lett 26(3):404","journal-title":"Oncol Lett"},{"issue":"10","key":"11621_CR39","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.3724\/abbs.2023158","volume":"55","author":"A Song","year":"2023","unstructured":"Song A, Mao Y, Wei H (2023) GLUT5: structure, functions, diseases and potential applications. Acta Biochim Biophys Sin 55(10):1519","journal-title":"Acta Biochim Biophys Sin"},{"issue":"8","key":"11621_CR40","doi-asserted-by":"publisher","first-page":"5056","DOI":"10.1074\/jbc.M808128200","volume":"284","author":"S Barone","year":"2009","unstructured":"Barone S et al (2009) Slc2a5 (Glut5) is essential for the absorption of fructose in the intestine and generation of fructose-induced hypertension. J Biol Chem 284(8):5056\u20135066","journal-title":"J Biol Chem"},{"issue":"1","key":"11621_CR41","doi-asserted-by":"publisher","first-page":"9299","DOI":"10.1038\/s41598-019-45803-x","volume":"9","author":"I Zwarts","year":"2019","unstructured":"Zwarts I et al (2019) Identification of the fructose transporter GLUT5 (SLC2A5) as a novel target of nuclear receptor LXR. Sci Rep 9(1):9299","journal-title":"Sci Rep"},{"key":"11621_CR42","doi-asserted-by":"crossref","unstructured":"Zamora-Leon SP et al (1996) Expression of the fructose transporter GLUT5 in human breast cancer. Proceedings of the National Academy of Sciences, 93(5): pp. 1847\u20131852","DOI":"10.1073\/pnas.93.5.1847"},{"issue":"4","key":"11621_CR43","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.nucmedbio.2010.11.004","volume":"38","author":"M Wuest","year":"2011","unstructured":"Wuest M et al (2011) Radiopharmacological evaluation of 6-deoxy-6-[18F] fluoro-D-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer. Nucl Med Biol 38(4):461\u2013475","journal-title":"Nucl Med Biol"},{"key":"11621_CR44","doi-asserted-by":"publisher","first-page":"111720","DOI":"10.1016\/j.ejmech.2019.111720","volume":"183","author":"Y Pu","year":"2019","unstructured":"Pu Y et al (2019) Dual-targeting liposomes with active recognition of GLUT5 and \u03b1v\u03b23 for triple-negative breast cancer. Eur J Med Chem 183:111720","journal-title":"Eur J Med Chem"},{"key":"11621_CR45","doi-asserted-by":"publisher","first-page":"e3804","DOI":"10.7717\/peerj.3804","volume":"5","author":"X Fan","year":"2017","unstructured":"Fan X et al (2017) Increased utilization of fructose has a positive effect on the development of breast cancer. PeerJ 5:e3804","journal-title":"PeerJ"},{"issue":"1","key":"11621_CR46","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40170-021-00246-9","volume":"9","author":"RJ Liang","year":"2021","unstructured":"Liang RJ et al (2021) GLUT5 (SLC2A5) enables fructose-mediated proliferation independent of ketohexokinase. Cancer Metabolism 9(1):12","journal-title":"Cancer Metabolism"},{"issue":"3","key":"11621_CR47","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1681\/ASN.2008060576","volume":"20","author":"P Cirillo","year":"2009","unstructured":"Cirillo P et al (2009) Ketohexokinase-dependent metabolism of fructose induces proinflammatory mediators in proximal tubular cells. J Am Soc Nephrol 20(3):545\u2013553","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"11621_CR48","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.7150\/ijms.108549","volume":"22","author":"X Chen","year":"2025","unstructured":"Chen X et al (2025) Fructose Metabolism in Cancer: Molecular Mechanisms and Therapeutic Implications. Int J Med Sci 22(11):2852","journal-title":"Int J Med Sci"},{"issue":"18","key":"11621_CR49","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1101\/gad.17420111","volume":"25","author":"DG Hardie","year":"2011","unstructured":"Hardie DG (2011) AMP-activated protein kinase\u2014an energy sensor that regulates all aspects of cell function. Genes Dev 25(18):1895\u20131908","journal-title":"Genes Dev"},{"issue":"4","key":"11621_CR50","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/cbin.10915","volume":"42","author":"R Ke","year":"2018","unstructured":"Ke R et al (2018) Mechanisms of AMPK in the maintenance of ATP balance during energy metabolism. Cell Biol Int 42(4):384\u2013392","journal-title":"Cell Biol Int"},{"key":"11621_CR51","doi-asserted-by":"crossref","unstructured":"Chen W et al (2021) The migration of metastatic breast cancer cells is regulated by matrix stiffness via YAP signalling. Heliyon 7(2):e06252","DOI":"10.1016\/j.heliyon.2021.e06252"},{"key":"11621_CR52","doi-asserted-by":"crossref","unstructured":"Qin X et al (2020) Matrix stiffness modulates ILK-mediated YAP activation to control the drug resistance of breast cancer cells. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 1866(3):165625","DOI":"10.1016\/j.bbadis.2019.165625"},{"issue":"1","key":"11621_CR53","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12964-023-01043-1","volume":"21","author":"F-y Gao","year":"2023","unstructured":"Gao F-y et al (2023) c-MYC mediates the crosstalk between breast cancer cells and tumor microenvironment. Cell Communication Signal 21(1):28","journal-title":"Cell Communication Signal"},{"key":"11621_CR54","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3389\/fonc.2020.00428","volume":"10","author":"X Sun","year":"2020","unstructured":"Sun X et al (2020) Metabolic reprogramming in triple-negative breast cancer. Front Oncol 10:428","journal-title":"Front Oncol"},{"issue":"8","key":"11621_CR55","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1158\/0008-5472.CAN-22-1844","volume":"83","author":"J-H Fang","year":"2023","unstructured":"Fang J-H et al (2023) Fructose metabolism in tumor endothelial cells promotes angiogenesis by activating AMPK signaling and mitochondrial respiration. Cancer Res 83(8):1249\u20131263","journal-title":"Cancer Res"},{"issue":"1","key":"11621_CR56","doi-asserted-by":"publisher","first-page":"e70343","DOI":"10.1002\/hsr2.70343","volume":"8","author":"MS Hossen","year":"2025","unstructured":"Hossen MS et al (2025) A Review on the Role of Human Solute Carriers Transporters in Cancer. Health Sci Rep 8(1):e70343","journal-title":"Health Sci Rep"},{"issue":"4","key":"11621_CR57","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1007\/s12094-022-03015-2","volume":"25","author":"J Yang","year":"2023","unstructured":"Yang J et al (2023) Fructose utilization enhanced by GLUT5 promotes lung cancer cell migration via activating glycolysis\/AKT pathway. Clin Transl Oncol 25(4):1080\u20131090","journal-title":"Clin Transl Oncol"},{"issue":"7","key":"11621_CR58","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.21037\/tcr-24-2030","volume":"14","author":"D Wang","year":"2025","unstructured":"Wang D et al (2025) Stemness-hypoxia genes PPARGC1A, PFKFB3, and SLC2A5 are associated with prognosis and tumor immune microenvironment in hepatocellular carcinoma. Translational Cancer Res 14(7):4009","journal-title":"Translational Cancer Res"},{"issue":"4","key":"11621_CR59","first-page":"3547","volume":"18","author":"Z Zhang","year":"2018","unstructured":"Zhang Z et al (2018) PI3K\/Akt and HIF\u20131 signaling pathway in hypoxia\u2013ischemia. Mol Med Rep 18(4):3547\u20133554","journal-title":"Mol Med Rep"},{"issue":"1","key":"11621_CR60","doi-asserted-by":"publisher","first-page":"10194","DOI":"10.1038\/srep10194","volume":"5","author":"R Thakur","year":"2015","unstructured":"Thakur R et al (2015) Inhibition of STAT3, FAK and Src mediated signaling reduces cancer stem cell load, tumorigenic potential and metastasis in breast cancer. Sci Rep 5(1):10194","journal-title":"Sci Rep"},{"issue":"1","key":"11621_CR61","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13046-016-0427-7","volume":"35","author":"G Song","year":"2016","unstructured":"Song G et al (2016) TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K\/AKT and MAPK pathway. J Experimental Clin Cancer Res 35(1):148","journal-title":"J Experimental Clin Cancer Res"},{"issue":"5","key":"11621_CR62","doi-asserted-by":"publisher","first-page":"708","DOI":"10.2174\/1389201023666220728150544","volume":"24","author":"Y Luo","year":"2023","unstructured":"Luo Y et al (2023) Vernodalin suppresses tumor proliferation and increases apoptosis of gastric cancer cells through attenuation of FAK\/PI3K\/AKT\/mTOR and MAPKs signaling pathways. Curr Pharm Biotechnol 24(5):708\u2013171","journal-title":"Curr Pharm Biotechnol"},{"issue":"2","key":"11621_CR63","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149(2):274\u2013293","journal-title":"Cell"},{"issue":"5","key":"11621_CR64","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3390\/ijms20051117","volume":"20","author":"G Sang\u00fcesa","year":"2019","unstructured":"Sang\u00fcesa G et al (2019) mTOR is a key protein involved in the metabolic effects of simple sugars. Int J Mol Sci 20(5):1117","journal-title":"Int J Mol Sci"},{"issue":"1","key":"11621_CR65","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s10020-024-00879-8","volume":"30","author":"N Hadzi-Petrushev","year":"2024","unstructured":"Hadzi-Petrushev N et al (2024) GLUT5-overexpression-related tumorigenic implications. Mol Med 30(1):114. https:\/\/doi.org\/10.1186\/s10020-024-00879-8","journal-title":"Mol Med"},{"issue":"25","key":"11621_CR66","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1038\/onc.2012.320","volume":"32","author":"A Bianchi-Smiraglia","year":"2013","unstructured":"Bianchi-Smiraglia A, Paesante S, Bakin AV (2013) Integrin \u03b25 contributes to the tumorigenic potential of breast cancer cells through the Src-FAK and MEK-ERK signaling pathways. Oncogene 32(25):3049\u20133058","journal-title":"Oncogene"},{"issue":"6","key":"11621_CR67","doi-asserted-by":"publisher","first-page":"584","DOI":"10.3892\/etm.2021.10016","volume":"21","author":"L Yang","year":"2021","unstructured":"Yang L et al (2021) Diclofenac impairs the proliferation and glucose metabolism of triple-negative breast cancer cells by targeting the c-Myc pathway. Experimental therapeutic Med 21(6):584","journal-title":"Experimental therapeutic Med"},{"key":"11621_CR68","doi-asserted-by":"publisher","first-page":"176914","DOI":"10.1016\/j.ejphar.2024.176914","volume":"981","author":"A Raj","year":"2024","unstructured":"Raj A et al (2024) Targeting overexpressed surface proteins: A new strategy to manage the recalcitrant triple-negative breast cancer. Eur J Pharmacol 981:176914","journal-title":"Eur J Pharmacol"},{"key":"11621_CR69","doi-asserted-by":"crossref","unstructured":"Tsai C-C et al (2024) Progesterone modulates cell growth via integrin \u03b1v\u03b23-dependent pathway in progesterone receptor-negative MDA-MB-231 cells. Heliyon 10(13)e:34006","DOI":"10.1016\/j.heliyon.2024.e34006"},{"issue":"2","key":"11621_CR70","doi-asserted-by":"publisher","first-page":"S658","DOI":"10.1016\/j.ijrobp.2013.06.1744","volume":"87","author":"T Lautenschlaeger","year":"2013","unstructured":"Lautenschlaeger T et al (2013) Cilengitide Inhibits Proliferation and Shows Combined Effects With Radiation in Breast Cancer Cell Lines. Int J Radiat Oncol Biol Phys 87(2):S658","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"11621_CR71","doi-asserted-by":"publisher","first-page":"108880","DOI":"10.1016\/j.nucmedbio.2024.108880","volume":"128","author":"A Josefsson","year":"2024","unstructured":"Josefsson A et al (2024) Evaluation of targeting \u03b1V\u03b23 in breast cancers using RGD peptide-based agents. Nucl Med Biol 128:108880","journal-title":"Nucl Med Biol"},{"issue":"6","key":"11621_CR72","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/j.gendis.2021.09.002","volume":"9","author":"N Suwannakul","year":"2022","unstructured":"Suwannakul N et al (2022) Targeting fructose metabolism by glucose transporter 5 regulation in human cholangiocarcinoma. Genes Dis 9(6):1727\u20131741","journal-title":"Genes Dis"},{"issue":"2","key":"11621_CR73","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1124\/mol.117.110007","volume":"93","author":"M Wuest","year":"2018","unstructured":"Wuest M et al (2018) Molecular Imaging of GLUT1 and GLUT5 in Breast Cancer: A Multitracer Positron Emission Tomography Imaging Study in Mice. Mol Pharmacol 93(2):79\u201389. https:\/\/doi.org\/10.1124\/mol.117.110007","journal-title":"Mol Pharmacol"},{"issue":"1","key":"11621_CR74","doi-asserted-by":"publisher","first-page":"24240","DOI":"10.1038\/srep24240","volume":"6","author":"AM George Thompson","year":"2016","unstructured":"George Thompson AM et al (2016) Discovery of a specific inhibitor of human GLUT5 by virtual screening and in vitro transport evaluation. Sci Rep 6(1):24240","journal-title":"Sci Rep"},{"issue":"1","key":"11621_CR75","doi-asserted-by":"publisher","first-page":"12804","DOI":"10.1038\/srep12804","volume":"5","author":"AM George Thompson","year":"2015","unstructured":"George Thompson AM et al (2015) Inhibition of human GLUT1 and GLUT5 by plant carbohydrate products; insights into transport specificity. Sci Rep 5(1):12804","journal-title":"Sci Rep"},{"key":"11621_CR76","doi-asserted-by":"publisher","first-page":"106694","DOI":"10.1016\/j.phrs.2023.106694","volume":"189","author":"Y Gu","year":"2023","unstructured":"Gu Y et al (2023) The challenges and opportunities of \u03b1v\u03b23-based therapeutics in cancer: From bench to clinical trials. Pharmacol Res 189:106694","journal-title":"Pharmacol Res"},{"key":"11621_CR77","doi-asserted-by":"publisher","first-page":"105946","DOI":"10.1016\/j.jddst.2024.105946","volume":"99","author":"S Korake","year":"2024","unstructured":"Korake S et al (2024) \u03b1v\u03b23 integrin-targeted pH-responsive dendritic nanocarriers for enhanced anti-tumor efficacy of docetaxel against breast cancer. J Drug Deliv Sci Technol 99:105946","journal-title":"J Drug Deliv Sci Technol"},{"issue":"5","key":"11621_CR78","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3390\/cancers11050692","volume":"11","author":"E Cruz da Silva","year":"2019","unstructured":"Cruz da Silva E et al (2019) Role of Integrins in Resistance to Therapies Targeting Growth Factor Receptors in Cancer. Cancers 11(5):692","journal-title":"Cancers"},{"key":"11621_CR79","doi-asserted-by":"publisher","first-page":"896297","DOI":"10.3389\/fcell.2022.896297","volume":"10","author":"J Groenendyk","year":"2022","unstructured":"Groenendyk J et al (2022) Loss of the fructose transporter SLC2A5 inhibits cancer cell migration. Front Cell Dev Biology 10:896297","journal-title":"Front Cell Dev Biology"},{"key":"11621_CR80","doi-asserted-by":"publisher","unstructured":"Chen W-L et al (2020) GLUT5-mediated fructose utilization drives lung cancer growth by stimulating fatty acid synthesis and AMPK\/mTORC1 signaling. JCI Insight 5(3). https:\/\/doi.org\/10.1172\/jci.insight.131596","DOI":"10.1172\/jci.insight.131596"},{"issue":"1","key":"11621_CR81","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s11033-025-10296-7","volume":"52","author":"J Aakriti","year":"2025","unstructured":"Aakriti J et al (2025) Focal adhesion kinase (FAK): emerging target for drug-resistant malignant tumors. Mol Biol Rep 52(1):248. https:\/\/doi.org\/10.1007\/s11033-025-10296-7","journal-title":"Mol Biol Rep"},{"key":"11621_CR82","doi-asserted-by":"publisher","unstructured":"Hu H-H et al (2024) Roles and inhibitors of FAK in cancer: current advances and future directions. Front Pharmacol 15\u20132024. https:\/\/doi.org\/10.3389\/fphar.2024.1274209","DOI":"10.3389\/fphar.2024.1274209"},{"key":"11621_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40170-021-00246-9","volume":"9","author":"RJ Liang","year":"2021","unstructured":"Liang RJ et al (2021) GLUT5 (SLC2A5) enables fructose-mediated proliferation independent of ketohexokinase. Cancer Metabolism 9:1\u201313","journal-title":"Cancer Metabolism"},{"key":"11621_CR84","doi-asserted-by":"publisher","first-page":"e19328","DOI":"10.7717\/peerj.19328","volume":"13","author":"Y Li","year":"2025","unstructured":"Li Y et al (2025) Integrin signaling in tumor biology: mechanisms of intercellular crosstalk and emerging targeted therapies. PeerJ 13:e19328","journal-title":"PeerJ"},{"key":"11621_CR85","doi-asserted-by":"publisher","first-page":"812480","DOI":"10.3389\/fonc.2022.812480","volume":"12","author":"Q Li","year":"2022","unstructured":"Li Q et al (2022) Integrin-mediated tumorigenesis and its therapeutic applications. Front Oncol 12:812480","journal-title":"Front Oncol"},{"issue":"8","key":"11621_CR86","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41568-022-00485-y","volume":"22","author":"SR Taylor","year":"2022","unstructured":"Taylor SR et al (2022) Developing dietary interventions as therapy for cancer. Nat Rev Cancer 22(8):452\u2013466","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"11621_CR87","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41523-024-00715-6","volume":"11","author":"Q Zuo","year":"2025","unstructured":"Zuo Q et al (2025) Co-targeting of metabolism using dietary and pharmacologic approaches reduces breast cancer metastatic burden. npj Breast Cancer 11(1):3","journal-title":"npj Breast Cancer"},{"issue":"1","key":"11621_CR88","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s41231-024-00178-8","volume":"9","author":"K Schmidt","year":"2024","unstructured":"Schmidt K et al (2024) The combined treatment with ketogenic diet and metformin slows tumor growth in two mouse models of triple negative breast cancer. Translational Med Commun 9(1):21","journal-title":"Translational Med Commun"},{"issue":"2","key":"11621_CR89","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/JN9.0000000000000015","volume":"8","author":"Y-J Zhai","year":"2023","unstructured":"Zhai Y-J et al (2023) The emerging role of fasting-mimicking diets in cancer treatment. J Nutritional Oncol 8(2):66\u201370","journal-title":"J Nutritional Oncol"},{"issue":"8","key":"11621_CR90","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1158\/2159-8290.CD-24-0002","volume":"14","author":"J Prakash","year":"2024","unstructured":"Prakash J, Shaked Y (2024) The interplay between extracellular matrix remodeling and cancer therapeutics. Cancer Discov 14(8):1375\u20131388","journal-title":"Cancer Discov"},{"issue":"1","key":"11621_CR91","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40170-021-00246-9","volume":"9","author":"RJ Liang","year":"2021","unstructured":"Liang RJ et al (2021) GLUT5 (SLC2A5) enables fructose-mediated proliferation independent of ketohexokinase. Cancer Metabolism 9(1):12. https:\/\/doi.org\/10.1186\/s40170-021-00246-9","journal-title":"Cancer Metabolism"},{"key":"11621_CR92","doi-asserted-by":"publisher","unstructured":"Guerrero M, Kowkabany G, Bao Y (2024) The roles of GLUT5 in cancer progression, metastasis, and drug resistance. GPD 3(4). https:\/\/doi.org\/10.36922\/gpd.4171","DOI":"10.36922\/gpd.4171"},{"issue":"6","key":"11621_CR93","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.ccell.2017.10.016","volume":"32","author":"E Cosset","year":"2017","unstructured":"Cosset E et al (2017) Glut3 addiction is a druggable vulnerability for a molecularly defined subpopulation of glioblastoma. Cancer Cell 32(6):856\u2013868e5","journal-title":"Cancer Cell"},{"issue":"1","key":"11621_CR94","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s11658-024-00682-7","volume":"30","author":"J Zhang","year":"2025","unstructured":"Zhang J et al (2025) Systematic and comprehensive insights into HIF-1 stabilization under normoxic conditions: implications for cellular adaptation and therapeutic strategies in cancer. Cell Mol Biol Lett 30(1):2. https:\/\/doi.org\/10.1186\/s11658-024-00682-7","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"11621_CR95","doi-asserted-by":"publisher","first-page":"2546680","DOI":"10.1080\/21505594.2025.2546680","volume":"16","author":"S Jia","year":"2025","unstructured":"Jia S et al (2025) Roles of hypoxia inducible factors in viral infection: Are they a potential therapeutic target? Virulence 16(1):2546680","journal-title":"Virulence"},{"issue":"14","key":"11621_CR96","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.3390\/molecules30142919","volume":"30","author":"A Joshi","year":"2025","unstructured":"Joshi A et al (2025) Structure-Based Design of Small-Molecule Inhibitors of Human Interleukin-6. Molecules 30(14):2919","journal-title":"Molecules"},{"key":"11621_CR97","doi-asserted-by":"publisher","first-page":"2050313X2514088","DOI":"10.1177\/2050313X251408894","volume":"14","author":"RY Rajesh","year":"2026","unstructured":"Rajesh RY et al (2026) Tocilizumab-induced psoriatic dermatitis in polyarticular juvenile idiopathic arthritis: A rare case report. Sage Open Med Case Rep 14:2050313X251408894","journal-title":"Sage Open Med Case Rep"},{"issue":"23","key":"11621_CR98","doi-asserted-by":"publisher","first-page":"8529","DOI":"10.3390\/molecules27238529","volume":"27","author":"AJ Boyle","year":"2022","unstructured":"Boyle AJ et al (2022) PET Imaging of Fructose Metabolism in a Rodent Model of Neuroinflammation with 6-[18F] fluoro-6-deoxy-D-fructose. Molecules 27(23):8529","journal-title":"Molecules"},{"issue":"1","key":"11621_CR99","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1186\/s12951-022-01623-2","volume":"20","author":"J Xia","year":"2022","unstructured":"Xia J et al (2022) Targeting therapy and tumor microenvironment remodeling of triple-negative breast cancer by ginsenoside Rg3 based liposomes. J Nanobiotechnol 20(1):414","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"11621_CR100","doi-asserted-by":"publisher","first-page":"561","DOI":"10.4081\/oncol.2022.561","volume":"16","author":"L Szablewski","year":"2022","unstructured":"Szablewski L (2022) Glucose transporters as markers of diagnosis and prognosis in cancer diseases. Oncol reviews 16(1):561","journal-title":"Oncol reviews"},{"issue":"17","key":"11621_CR101","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1002\/1873-3468.14794","volume":"598","author":"T Zakic","year":"2024","unstructured":"Zakic T et al (2024) Redox and metabolic reprogramming in breast cancer and cancer-associated adipose tissue. FEBS Lett 598(17):2106\u20132134","journal-title":"FEBS Lett"},{"issue":"2","key":"11621_CR102","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1124\/mol.117.110007","volume":"93","author":"M Wuest","year":"2018","unstructured":"Wuest M et al (2018) Molecular imaging of GLUT1 and GLUT5 in breast cancer: a multitracer positron emission tomography imaging study in mice. Mol Pharmacol 93(2):79\u201389","journal-title":"Mol Pharmacol"},{"key":"11621_CR103","doi-asserted-by":"publisher","first-page":"215617","DOI":"10.1016\/j.canlet.2022.215617","volume":"534","author":"Z Shen","year":"2022","unstructured":"Shen Z et al (2022) GLUT5-KHK axis-mediated fructose metabolism drives proliferation and chemotherapy resistance of colorectal cancer. Cancer Lett 534:215617","journal-title":"Cancer Lett"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11621-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11621-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11621-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T13:04:46Z","timestamp":1772543086000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11621-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":103,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11621"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11621-4","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"ChatGPT used for the grammar and language corrections only.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI use declaration"}}],"article-number":"449"}}